EXTH-54. Bcl-2/Bcl-xL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO

MLA

Markus D. Siegelin, et al. “EXTH-54. Bcl-2/Bcl-XL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO.” Neuro-Oncology, vol. 20, Nov. 2018, p. vi96. EBSCOhost, https://doi.org/10.1093/neuonc/noy148.402.

APA

Markus D. Siegelin, Richard E. Kast, Georg Karpel-Massler, Marc-Eric Halatsch, Annika Dwucet, & Christian Rainer Wirtz. (2018). EXTH-54. Bcl-2/Bcl-xL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO. Neuro-Oncology, 20, vi96. https://doi.org/10.1093/neuonc/noy148.402

Chicago

Markus D. Siegelin, Richard E. Kast, Georg Karpel-Massler, Marc-Eric Halatsch, Annika Dwucet, and Christian Rainer Wirtz. 2018. “EXTH-54. Bcl-2/Bcl-XL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO.” Neuro-Oncology 20 (November): vi96. doi:10.1093/neuonc/noy148.402.